Hematologic Malignancies : A Guide to the Clinical Impact of Staging and Risk Stratification Systems

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 90 Minutes

Overview

Watch this certified, on-demand webcast featuring Francesca Van Sant, CRNP, AOCNP, for a comprehensive review of the prognostic risk stratification and staging criteria used for various hematologic malignancies (leukemias, lymphomas, myelodysplastic syndromes, myeloproliferative neoplasms, and multiple myeloma). Participants will become familiar with the clinical tools and scoring systems that help stratify patients by risk and predict outcomes, and through case-based discussions, will gain insights into the clinical implications of staging and prognostic scoring systems.

Learning Objectives

  1. Identify key factors used in staging criteria and prognostic risk stratification for hematologic malignancies 
  2. Describe various staging and prognostic scoring tools seen in hematologic malignancies including leukemias, lymphomas, myelodysplastic and myeloproliferative syndromes, and multiple myeloma
  3. Recognize the role and implications of molecular and genetic testing in providing prognostic information that leads to treatment decisions
  4. Explain the clinical implications of the staging and prognostic scoring systems in hematologic malignancies using patient case scenarios

Target Audience:

This activity is intended for oncology nurse practitioners, physician assistants, nurses, and other healthcare providers involved in the care of cancer patients.

 

This educational activity is supported by independent medical education grants from GSK and Merck Sharp & Dohme Corp.

Presented By

                                                                  

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.50 credit.
Course opens: 
06/11/2025
Course expires: 
06/11/2026
Cost:
$0.00
Rating: 
0

Faculty

Francesca Van Sant, CRNP, AOCNP

Francesca Van Sant is a Nurse Practitioner specializing in hematology/oncology, based at the Center for Cancer and Blood Disorders in Bethesda, MD. With a Bachelor of Science in Nursing from Georgetown University and a Master of Science in Nursing with an oncology specialty from Duke University. Francesca brings over a decade of experience to her practice. Began her career treating benign and malignant hematology patients at the Sidney Kimmel Cancer Center at Johns Hopkins Hospital then transitioned to nurse practitioner role managing hematologic and solid tumor patients. 

Certified as an Advanced Oncology Certified Nurse Practitioner (AOCNP), she provides compassionate care to patients and families facing cancer and blood disorders. As a member of ONS and APSHO, Francesca is committed to providing excellent evidence based care in a holistic manner to treat the underlying disease while addressing the unique needs and concerns of each patient.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Francesca Van Sant, CRNP, AOCNP  discloses that she is on a speaker’s bureau and is a consultant with Fennec Pharmaceuticals Inc. and was on advisory board with Abbvie+Genmab but that relationship has ended, during the past 24 months

Available Credit

  • 1.50 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

    Horizon CME designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 1.50 credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to internet required

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above